PT  - JOURNAL ARTICLE
AU  - Fantini, Dalia
AU  - Fisk, Abigail
AU  - Leon-Vargas, Andres
AU  - Lynch, Emma
AU  - Scarlett, Christine
AU  - Stafford, Devon
AU  - Zegarra, Marcos
AU  - Bielewicz, Brady John
TI  - DuckDerm: An Improved Water Infiltration Prevention Product for Long-Term Intravenous Therapy Patients
AID  - 10.1101/2024.11.25.24317953
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.11.25.24317953
4099  - http://medrxiv.org/content/early/2024/11/28/2024.11.25.24317953.short
4100  - http://medrxiv.org/content/early/2024/11/28/2024.11.25.24317953.full
AB  - We propose an alternative to the widely implemented intravenous (IV) shower guard solution, AnchorDry, which we have coined DuckDerm. The AnchorDry is a rigid square of plastic with an adhesive border on the outer edge. This design does not adhere to the arm during the bathing period as it cannot withstand the range of motion (ROM) patients exert, leaving the Tegaderm and IV site vulnerable to water intrusion. Significant water intrusion compromises the IV site, leaving it susceptible to infection. By interviewing seasoned clinicians, nursing faculty, students, and patient care technicians (PCTs) we ascertained ineffective shower guard fit is an issue rooted in design and material selections. We have found that nurses and PCTs are often getting creative to modify or make their own IV shower guards.After several design iterations and consultations with several University of Pittsburgh nursing faculty, we mass-manufactured our design. The DuckDerm body is composed of 1 mil polyethylene plastic, which is biocompatible and able to move with the skin, a hypoallergenic adhesive, and a foam barrier to envelop the Tegaderm. Based on this initial testing, we formulated our design specifications: (1) maintaining the patient’s ROM, (2) ease of use for both patients and clinicians, and (3) preventing water infiltration. We provided our manufactured design and interviewed nursing students and faculty (n=21) to address the following criteria: (1) the DuckDerm must be simple for clinicians to apply to not take away time from more essential tasks and to encourage patient self-application; (2) the DuckDerm must retain functionality without providing discomfort to the patient during use and removal. We also conducted functionality testing using our manufactured design to address the following criteria on volunteers (n=11): the DuckDerm must (1) contain all the IV components within the foam barrier, (2) not place unnecessary pressure on components to dislodge, and (3) fit securely on the patient’s arm. Additionally, the Duckderm must adhere to the skin while subjected to running water and movement, and the DuckDerm must be able to provide a sufficient range of motion about the antecubital space to allow for arm movements required while showering. The Duckderm outperformed the currently utilized solution in both verbal feedback and assessment by potential users (nurses and PCTs) and in functionality testing; therefore, we propose our novel design as an alternative to the currently employed AnchorDry.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to thank the University of Pittsburghs Bioengineering Department for funding, facilities, and assistance in the completion of this medical product design project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRC of the University of Pittsburgh gave ethical approval for this work Ethics committee/IRC of the University of Pittsburgh waived ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors